Navigation Links
1st Case Report of Using Single-Site Cannulation ECMO to Treat SynCardia Total Artificial Heart Patient Published in Journal of Cardiothoracic Surgery
Date:8/21/2013

TUCSON, Ariz., Aug. 21, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that doctors at EJK Duisburg in Germany have published the first case report detailing use of single-site cannulation with extracorporeal membrane oxygenation (ECMO) to successfully treat adult respiratory distress syndrome in a patient implanted with the SynCardia temporary Total Artificial Heart. The case report was published in the August issue of the Journal of Cardiothoracic Surgery.

(Photo:  http://photos.prnewswire.com/prnh/20130821/LA67168)

Before the Total Artificial Heart implant, the 55-year-old patient was supported by veno-arterial ECMO due to refractory cardiogenic shock and severe respiratory failure. Once the Total Artificial Heart was implanted, the patient was weaned from extracorporeal circulation. However, due to pre-existing respiratory failure, doctors decided to implement veno-venous ECMO using a single-site bicaval dual-lumen catheter placed in the right internal jugular vein instead of conventional dual-site cannulation.

"In this context single-site veno-venous cannulation proved to have numerous advantages: it is simple to perform, it minimizes the risk of cannula dislodgement during patient care, reduces the risk of catheter related infections and finally allows early sternum closure," according to the report written by Dr. Sotirios Spiliopoulos, surgeons Dr. Guenes Dogan and Dr. '/>"/>

SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
5. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
6. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
7. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
8. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
9. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
10. Chindex International, Inc. to Report First Quarter 2012 Financial Results
11. Pharma IQs Solubility Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... Auf seiner am ... veranstalteten F&E-Tagung meldete Astellas Fortschritte im ... Forschungsrahmenprogramms. Die Tagung bot Astellas die Gelegenheit, ... Programme und die Konzernstrategie des Unternehmens zu ... aktuelle Meldungen zu den Astellas-Initiativen in den ...
(Date:7/13/2014)... , July 13, 2014  Eli Lilly ... announced results from its non-clinical study in genetically ... version of the beta-amyloid antibody N3pG and beta-secretase ... therapy was more effective in removing clumps of ... that is thought to lead to Alzheimer,s disease ...
(Date:7/11/2014)... , July 11, 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. ... vegetable-glycol solution for use in portable vaporizers, which ... active ingredients in cannabis, cannabidiol offers consumers a ... devices, and other vaporizer technology. Photo ... naturally contains 483 different compounds which are currently ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2
... is,being released by The Philadelphia AIDS Consortium:, ... with its network of eleven (11) community-based organization,sites ... of 30 AmeriCorps ACTS members working throughout New,Jersey, ... 2008: 9 a.m. until Noon; Media Focused,Event 10:30 ...
... highlights:, In a small study, miniaturized heart pumps ... The devices are not approved for general use ... In a recent study, nine,pediatric patients with severe heart ... days with miniaturized heart assist pumps while,awaiting a heart ...
Cached Medicine Technology:Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures 2American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant 2
(Date:7/13/2014)... (PRWEB) July 13, 2014 MarketsandMarkets ... Market [3D Modeling; 3D Scanning; 3D rendering; Layout ... and Analysis (2013 - 2018)”, which analyzes and ... in North America, Western Europe, Eastern Europe, Middle ... report also draws the competitive landscape of the ...
(Date:7/13/2014)... Seattle, WA (PRWEB) July 13, 2014 ... a longer recovery period from concussions, according to research ... Medicine’s ( AOSSM ) Annual Meeting. The research marks ... to concussion based on the known physical events that ... that patients with a long allele in the (GT)n ...
(Date:7/13/2014)... July 13, 2014 Recently, MyDressCity.com, one ... women’s special occasion outfits, has released its new range ... the new products are available at discounted prices. Worldwide ... 2014. , In the company’s online shop, there ... of them are made with great materials. MyDressCity.com’s hot ...
(Date:7/13/2014)... decreased ability to identify odors might indicate the ... examinations of the eye could indicate the build-up ... the brain, according to the results of four ... International Conference 2014 (AAIC 2014) in Copenhagen. , ... to identify odors was significantly associated with loss ...
(Date:7/13/2014)... Celebrity fitness trainer and former World Super ... with Aqua Health Labs for their flagship product PhytOriginal, ... The collaboration was recently announced live on ESPN Radio. ... actor, model, and a two time World Super Middleweight ... has prepared stars including Demi Moore, Hilary Swank and ...
Breaking Medicine News(10 mins):Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2
... Residents to Also Press For ... Immediate ... National House Call campaign visits New Mexico,today and urges residents to ... will slash physician payments 15,percent over the next two years. ...
... F. Murphy Appointed Director, First Ray and Stephanie ... Mellon University,announced today that it has received a ... establish the Ray and Stephanie Lane Center for,Computational ... and provide,support for doctoral and post-doctoral training in ...
... by German scientists may make blood doping and the ... hair. In the October print issue of The FASEB ... 100,000 hair follicles on each persons head have the ... primarily responsible for the creation of red blood cells, ...
... Position as the Global Leader in Endoscopic ... NDO Surgical, Inc. (NDO),announced that the ... the,Company,s Plicator II(TM) multiple implant technology for ... improved outcomes for,harder-to-treat gastroesophageal reflux disease (GERD) ...
... research that aligns patients and treatments., ... The,H. Lee Moffitt Cancer Center & ... health enterprise platform, to aid in its,development ... be used,to assimilate large quantities of diverse ...
... of Michigan has,received a national award for leadership excellence ... BCN received a DMAA Disease Management Leadership Award ... for Healthy Blue Living(SM),the innovative product BCN introduced in ... attempting to meet healthy lifestyle goals. "It is ...
Cached Medicine News:Health News:AMA Urges Congress to Stop Medicare Cuts 2Health News:Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology 2Health News:Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology 3Health News: New discovery leaves blood-doping athletes scratching their heads 2Health News:NDO Receives FDA 510(K) Clearance for Plicator II(TM) 2Health News:Moffitt Selects Microsoft's Azyxxi to Help Drive Personalized Cancer Treatment 2Health News:Blue Care Network of Michigan Earns National Leadership Award for Chronic Disease Management 2
Smooth pointed tips open to 3.0 mm. Cross action curved shafts. Tip to Angle Length: 12.0 mm. Round handle....
Straight, narrowed shafts with extra fine blunted tips. Smooth handle with dull finish....
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model....
Fine pointed grooved jaws with smooth curve from tip to finger grip style handle. Dull finish....
Medicine Products: